Activation of peroxisome proliferator-activated receptor γ suppresses inducible cyclooxygenase and nitric oxide synthase during oral mucosal ulcer healing

Journal of Physiology and Pharmacology

Volumn 53, Issue 2, 2002, Pages 159-169

  Slomiany, B L ^a   Slomiany, A ^a  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

COX 1; COX 2; NOS 2; Oral mucosa; PPAR ; Ulcer healing

Indexed keywords

CIGLITAZONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME REGULATION; INFLAMMATION; MOUTH MUCOSA; MOUTH ULCER; NONHUMAN; PROTEIN EXPRESSION; RAT; ULCER HEALING;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENZYME INDUCTION; ISOENZYMES; MEMBRANE PROTEINS; MOUTH MUCOSA; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; ORAL ULCER; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; WOUND HEALING;

EID: 0036289997     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Healing of oral and gastric ulcers: Effect of blood flow, epidermal growth factor and sensory innervation
2. Effect of chronic alcohol ingestion on buccal mucosal expression of bFGF and Cdk2 during ulcer healing
3. Role of endothelin-1 and interleukin-4 in buccal mucosal ulcer healing: Effect of chronic alcohol ingestion
4. Suppression of caspase-3 and nitric oxide synthase-2 during buccal mucosal ulcer healing
5. Aspirin ingestion impairs oral mucosal ulcer healing by inducing membrane-bound tumor necrosis factor-α release
6. Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2- and p38 mitogen-activated protein kinase-dependent TNF-α gene expression
7. Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1)
8. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells
9. Positive and negative regulation of NFκB by COX-2
10. Trafficking of endothelial nitric-oxide synthase in living cells
11. The transcriptional factor C/EBPβ is essential for inducible expression of of the cox-2 gene in macrophages but not in fibroblasts
12. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
13. Endogenously PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
14. Ligands for peroxisome proliferator-activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats
15. Increased expression of inducible niric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
16. Feedback control of cyclooxygenase-2 expression through PPARγ
17. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo
18. 2 inhibition of NFκB-DNA binding through covalent modification of the p50 subunit
19. Peroxisome proliferator-activated receptor-γ-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449
20. Pioglitazone, a specific PPAR-γ ligand inhibits aspirin-induced gastric injury in rats
21. Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcers in rats
22. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
23. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
24. Activation of human peroxisome proliferator-activated receptor (PPAR) Subtypes by pioglitazone
25. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor γ in lutein cells
26. Nonsteroidal anti-inflammatory drugs impair oral mucosal repair by eliciting disturbances in endothelin-converting enzyme-1 and constitutive nitric oxide synthase
27. 2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro
28. An inducible nirtric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity
29. Regulation of prostaglandin biosynthesis by inducible nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase
30. Pharmacological analysis of cyclooxygenase-1 in inflammation
31. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
32. 2
33. Constitutive nitric oxide synthases in rat gastric mucosa: Subcellular distribution, relative activity and different carboxyl-terminal antigenicity of the neuronal form compared with cerebellum
34. 2
35. Nitric oxide synthase/COX cross-talk: Nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production
36. Involvement of cyclooxygenase-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor
37. Inhibition of inducible nitric oxide synthase delays gastric ulcer healing in the rat
38. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers
39. Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
40. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats
41. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophage
42. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: Influence of nitric oxide
43. Cyclooxygenase in biology and disease
44. Approaches to nonsteroidal anti-inflammatory drug use in the high risk patient